Company
Biogen
238 Legal Matters
35
168
35

Biogen Company IP Overview

Practice Areas
Recent StatisticsView All
Subscription-Only
View Concierge Program
PatentsView All
Patents Issued Each Year
TrademarksView All
Trademark Applications Filed Each Year
LitigationView All
Cases Filed Each Year
Mikele Bicolli
Top 10 Pharmaceuticals Losing Exclusivity in the US in 2024
Mikele Bicolli
Mar 11, 2024
As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and the subsequent... Read More
Warren Woessner
Biogen v. EMD Serono – “A Nest of Limitations”
Warren Woessner
Oct 12, 2020
By now, other commentators have posted on this Fed. Cir. decision (Appeal no. 2019 -1133, Sept. 28, 2020)—and found it... Read More
scott eads
Fresh From the Bench: Latest Federal Circuit Court Cases
scott eads
Oct 6, 2020
CASE OF THE WEEK GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., Appeal No. 2018-1976, -2023 (Fed. Cir. Oct. 2, 2020)... Read More
Practice Areas
PatentsView All
Patents Issued Each Year
LitigationView All
Cases Filed Each Year
Recent StatisticsView All
Subscription-Only
View Concierge Program
TrademarksView All
Trademark Applications Filed Each Year
Mikele Bicolli
Top 10 Pharmaceuticals Losing Exclusivity in the US in 2024
Mikele Bicolli
Mar 11, 2024
As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and the subsequent... Read More
Warren Woessner
Biogen v. EMD Serono – “A Nest of Limitations”
Warren Woessner
Oct 12, 2020
By now, other commentators have posted on this Fed. Cir. decision (Appeal no. 2019 -1133, Sept. 28, 2020)—and found it... Read More
scott eads
Fresh From the Bench: Latest Federal Circuit Court Cases
scott eads
Oct 6, 2020
CASE OF THE WEEK GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., Appeal No. 2018-1976, -2023 (Fed. Cir. Oct. 2, 2020)... Read More